Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical Robotics ...

Surgical Robotics Technology has today unveiled the winners of the Surgical Robotics Industry Awards 2026, recognizing the ...

Representing a significant advancement in healthcare, endovascular procedures performed inside blood vessels embody the intersection of medicine and technology. By addressing critical conditions such ...

Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S.

BRAINTREE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced it has entered into an agreement with Emory University, which will allow the parties to ...

Microbot Medical Inc. MBOT recently announced that it has entered into an agreement with Emory University, which is likely to allow the entities to evaluate and explore the potential for future ...

Lovell Government Services will become Microbot's service-disabled veteran-owned small business vendor to supply federal ...

HINGHAM, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that LIBERTY was featured ...

Microbot Medical, a surgical robotics company, has announced the FDA approval to start its human clinical trials for the Liberty Endovascular Robotic Surgical System. The Liberty system was designed, ...

Microbot won FDA 510(k) clearance for its LIBERTY Endovascular Robotic System. MBOT shares jumped 22.9% after the announcement and are up 301.8% year to date. The LIBERTY system is compact, disposable ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.